Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer

por Noguchi, Susumu, Suminaga, Keiichiro, Kaki, Takahiro, Kawachi, Hiroaki, Fukao, Akari, Terashita, Satoshi, Horikawa, Sadao, Ikeue, Tatsuyoshi, Sugita, Takakazu
Publicado 2020

Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19—A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan

por Tamura, Shinobu, Kaki, Takahiro, Niwa, Mayako, Yamano, Yukiko, Kawai, Shintaro, Yamashita, Yusuke, Tanaka, Harumi, Saito, Yoshinobu, Kajimoto, Yoshinori, Koizumi, Yusuke, Yamaue, Hiroki, Nakao, Naoyuki, Nojiri, Takako, Hironishi, Masaya
Publicado 2022

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer

por Akamatsu, Hiroaki, Murakami, Eriko, Oyanagi, Jun, Shibaki, Ryota, Kaki, Takahiro, Takase, Eri, Tanaka, Masanori, Harutani, Yuhei, Yamagata, Nao, Okuda, Yuka, Furuta, Katsuyuki, Sugimoto, Takeya, Teraoka, Shunsuke, Hayata, Atsushi, Tokudome, Nahomi, Ozawa, Yuichi, Mori, Keita, Koh, Yasuhiro, Yamamoto, Nobuyuki
Publicado 2019